DMET™ (Drug-Metabolizing Enzymes and Transporters) microarray analysis of colorectal cancer patients with severe 5-fluorouracil-induced toxicity View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2013-06-13

AUTHORS

Enrica Rumiato, Elisa Boldrin, Alberto Amadori, Daniela Saggioro

ABSTRACT

Purpose5-fluorouracil (5-FU) has been widely used since the 1980s, and it remains the backbone of many chemotherapeutic combination regimens. However, its use is often limited by the occurrence of severe toxicity. Although several reports have shown the detrimental effect of some dihydropyrimidine dehydrogenase (DPYD) and thymidylate synthase (TYMS) gene polymorphisms in patients undergoing 5-FU-based treatment, they account for only a minority of toxicities.MethodsLooking for new candidate genetic variants associated with 5-FU-induced toxicity, we used the innovative genotyping microarray Affymetrix Drug-Metabolizing Enzymes and Transporters (DMET)™ Plus GeneChip that interrogates 1,936 genetic variants distributed in 231 genes involved in drug metabolism, excretion, and transport. To reduce variability, we analyzed samples from colorectal cancer patients who underwent fairly homogenous treatments (i.e., Machover or Folfox) and experienced G3 or G4 toxicity; control patients were matched for therapy and selected from those who did not disclose toxicity (G0–G1).ResultsPharmacogenetic genotyping showed no significant difference in DPYD and TYMS genetic variants distribution between cases and controls. However, other polymorphisms could account for 5-FU-induced toxicity, with the CHST1 rs9787901 and GSTM3 rs1799735 having the strongest association.ConclusionsAlthough exploratory, this study suggests that genetic polymorphisms not directly related to 5-FU pharmacokinetics and pharmacodynamics are involved in 5-FU-induced toxicity. Our data also indicates DMET™ microarray as a valid approach to discover new genetic determinants influencing chemotherapy-induced toxicity. More... »

PAGES

483-488

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00280-013-2210-1

DOI

http://dx.doi.org/10.1007/s00280-013-2210-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1032291442

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/23760813


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "5' Untranslated Regions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antimetabolites, Antineoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colorectal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dihydrouracil Dehydrogenase (NADP)", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorouracil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Deletion", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Dosage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genotype", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glutathione Transferase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Membrane Transport Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Microarray Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mutagenesis, Insertional", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pharmaceutical Preparations", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polymorphism, Single Nucleotide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sulfotransferases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thymidylate Synthase", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Via Gattamelata 64, 35128, Padova, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419546.b", 
          "name": [
            "Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Via Gattamelata 64, 35128, Padova, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rumiato", 
        "givenName": "Enrica", 
        "id": "sg:person.01174611161.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174611161.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Via Gattamelata 64, 35128, Padova, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419546.b", 
          "name": [
            "Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Via Gattamelata 64, 35128, Padova, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boldrin", 
        "givenName": "Elisa", 
        "id": "sg:person.0730464170.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730464170.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy", 
          "id": "http://www.grid.ac/institutes/grid.5608.b", 
          "name": [
            "Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Via Gattamelata 64, 35128, Padova, Italy", 
            "Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Amadori", 
        "givenName": "Alberto", 
        "id": "sg:person.0600652745.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600652745.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Via Gattamelata 64, 35128, Padova, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419546.b", 
          "name": [
            "Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Via Gattamelata 64, 35128, Padova, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Saggioro", 
        "givenName": "Daniela", 
        "id": "sg:person.01242265602.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242265602.64"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.tpj.6500012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032976098", 
          "https://doi.org/10.1038/sj.tpj.6500012"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6605052", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007371493", 
          "https://doi.org/10.1038/sj.bjc.6605052"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10038-002-8650-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053724153", 
          "https://doi.org/10.1007/s10038-002-8650-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2105-13-258", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041082187", 
          "https://doi.org/10.1186/1471-2105-13-258"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/tpj.2009.45", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043532859", 
          "https://doi.org/10.1038/tpj.2009.45"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-06-13", 
    "datePublishedReg": "2013-06-13", 
    "description": "Purpose5-fluorouracil (5-FU) has been widely used since the 1980s, and it remains the backbone of many chemotherapeutic combination regimens. However, its use is often limited by the occurrence of severe toxicity. Although several reports have shown the detrimental effect of some dihydropyrimidine dehydrogenase (DPYD) and thymidylate synthase (TYMS) gene polymorphisms in patients undergoing 5-FU-based treatment, they account for only a minority of toxicities.MethodsLooking for new candidate genetic variants associated with 5-FU-induced toxicity, we used the innovative genotyping microarray Affymetrix Drug-Metabolizing Enzymes and Transporters (DMET)\u2122 Plus GeneChip that interrogates 1,936 genetic variants distributed in 231 genes involved in drug metabolism, excretion, and transport. To reduce variability, we analyzed samples from colorectal cancer patients who underwent fairly homogenous treatments (i.e., Machover or Folfox) and experienced G3 or G4 toxicity; control patients were matched for therapy and selected from those who did not disclose toxicity (G0\u2013G1).ResultsPharmacogenetic genotyping showed no significant difference in DPYD and TYMS genetic variants distribution between cases and controls. However, other polymorphisms could account for 5-FU-induced toxicity, with the CHST1 rs9787901 and GSTM3 rs1799735 having the strongest association.ConclusionsAlthough exploratory, this study suggests that genetic polymorphisms not directly related to 5-FU pharmacokinetics and pharmacodynamics are involved in 5-FU-induced toxicity. Our data also indicates DMET\u2122 microarray as a valid approach to discover new genetic determinants influencing chemotherapy-induced toxicity.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00280-013-2210-1", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1088364", 
        "issn": [
          "0344-5704", 
          "1432-0843"
        ], 
        "name": "Cancer Chemotherapy and Pharmacology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "72"
      }
    ], 
    "keywords": [
      "colorectal cancer patients", 
      "dihydropyrimidine dehydrogenase", 
      "cancer patients", 
      "chemotherapy-induced toxicity", 
      "synthase gene polymorphisms", 
      "Drug-Metabolizing Enzymes", 
      "genetic variants", 
      "G4 toxicity", 
      "combination regimens", 
      "control patients", 
      "severe toxicity", 
      "gene polymorphisms", 
      "patients", 
      "candidate genetic variants", 
      "drug metabolism", 
      "strong association", 
      "genetic polymorphisms", 
      "significant differences", 
      "genetic determinants", 
      "toxicity", 
      "new genetic determinants", 
      "treatment", 
      "polymorphism", 
      "detrimental effects", 
      "variant distribution", 
      "regimens", 
      "pharmacodynamics", 
      "therapy", 
      "pharmacokinetics", 
      "excretion", 
      "GSTM3", 
      "ConclusionsAlthough", 
      "valid approach", 
      "DMET", 
      "variants", 
      "association", 
      "metabolism", 
      "report", 
      "genotyping", 
      "homogenous treatment", 
      "G3", 
      "transporters", 
      "microarrays", 
      "determinants", 
      "minority", 
      "differences", 
      "control", 
      "dehydrogenase", 
      "study", 
      "cases", 
      "GeneChip", 
      "occurrence", 
      "genes", 
      "effect", 
      "enzyme", 
      "use", 
      "data", 
      "samples", 
      "variability", 
      "analysis", 
      "approach", 
      "transport", 
      "distribution", 
      "backbone", 
      "Purpose5-fluorouracil", 
      "chemotherapeutic combination regimens", 
      "minority of toxicities", 
      "new candidate genetic variants", 
      "innovative genotyping microarray Affymetrix Drug-Metabolizing Enzymes", 
      "genotyping microarray Affymetrix Drug-Metabolizing Enzymes", 
      "microarray Affymetrix Drug-Metabolizing Enzymes", 
      "Affymetrix Drug-Metabolizing Enzymes", 
      "Plus GeneChip", 
      "ResultsPharmacogenetic genotyping", 
      "TYMS genetic variants distribution", 
      "genetic variants distribution", 
      "CHST1 rs9787901", 
      "rs9787901"
    ], 
    "name": "DMET\u2122 (Drug-Metabolizing Enzymes and Transporters) microarray analysis of colorectal cancer patients with severe 5-fluorouracil-induced toxicity", 
    "pagination": "483-488", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1032291442"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00280-013-2210-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "23760813"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00280-013-2210-1", 
      "https://app.dimensions.ai/details/publication/pub.1032291442"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:30", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_610.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00280-013-2210-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00280-013-2210-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00280-013-2210-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00280-013-2210-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00280-013-2210-1'


 

This table displays all metadata directly associated to this object as RDF triples.

265 TRIPLES      22 PREDICATES      129 URIs      115 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00280-013-2210-1 schema:about N10cfb2d194c64d9dbb40dc3a0c8507f9
2 N1458180e824645f0850e5ad8ace8c521
3 N304c3de0c74d4b0c9243fcee067ea5ff
4 N37469ddd80e04c24913f4e37b722a9f8
5 N553f93ccf3884d648ebeedd461df1950
6 N6095769b702e4e9795fc26edc215e968
7 N62823736846b434b84f576126bf9f821
8 N6757db1e348b457f81d3e5ca690744c9
9 N7222c445c9c64be0a6e593c26b1402c6
10 N72238aca9cf144d3b770f089bcc64d18
11 N74ea7aecae9747ac9fc40b8853f71987
12 N9367311168524a66bab70f990649fe09
13 N9bb3ff9dc760438398e4ac8bdd277db0
14 Na2f0888ab7124941ac9b05a30a8f21ad
15 Nab670325b66544eca4755b10debd3daa
16 Nae26aa2d05bf4cb892ce0504d520f53b
17 Nb1ffdcf506994338805807a6987dc78a
18 Nb5f43d1d989a484f90b7d2f9547172fc
19 Nc8bc6f76b80d414eac3c4fc5fd73442e
20 anzsrc-for:11
21 anzsrc-for:1112
22 anzsrc-for:1115
23 schema:author N180545b060814c6c9adb03bd083932e5
24 schema:citation sg:pub.10.1007/s10038-002-8650-9
25 sg:pub.10.1038/sj.bjc.6605052
26 sg:pub.10.1038/sj.tpj.6500012
27 sg:pub.10.1038/tpj.2009.45
28 sg:pub.10.1186/1471-2105-13-258
29 schema:datePublished 2013-06-13
30 schema:datePublishedReg 2013-06-13
31 schema:description Purpose5-fluorouracil (5-FU) has been widely used since the 1980s, and it remains the backbone of many chemotherapeutic combination regimens. However, its use is often limited by the occurrence of severe toxicity. Although several reports have shown the detrimental effect of some dihydropyrimidine dehydrogenase (DPYD) and thymidylate synthase (TYMS) gene polymorphisms in patients undergoing 5-FU-based treatment, they account for only a minority of toxicities.MethodsLooking for new candidate genetic variants associated with 5-FU-induced toxicity, we used the innovative genotyping microarray Affymetrix Drug-Metabolizing Enzymes and Transporters (DMET)™ Plus GeneChip that interrogates 1,936 genetic variants distributed in 231 genes involved in drug metabolism, excretion, and transport. To reduce variability, we analyzed samples from colorectal cancer patients who underwent fairly homogenous treatments (i.e., Machover or Folfox) and experienced G3 or G4 toxicity; control patients were matched for therapy and selected from those who did not disclose toxicity (G0–G1).ResultsPharmacogenetic genotyping showed no significant difference in DPYD and TYMS genetic variants distribution between cases and controls. However, other polymorphisms could account for 5-FU-induced toxicity, with the CHST1 rs9787901 and GSTM3 rs1799735 having the strongest association.ConclusionsAlthough exploratory, this study suggests that genetic polymorphisms not directly related to 5-FU pharmacokinetics and pharmacodynamics are involved in 5-FU-induced toxicity. Our data also indicates DMET™ microarray as a valid approach to discover new genetic determinants influencing chemotherapy-induced toxicity.
32 schema:genre article
33 schema:inLanguage en
34 schema:isAccessibleForFree false
35 schema:isPartOf N6db7f6cb8711468d8bfdc4294b2586aa
36 Nd36651f03ae2418c9b6decbbf5986380
37 sg:journal.1088364
38 schema:keywords Affymetrix Drug-Metabolizing Enzymes
39 CHST1 rs9787901
40 ConclusionsAlthough
41 DMET
42 Drug-Metabolizing Enzymes
43 G3
44 G4 toxicity
45 GSTM3
46 GeneChip
47 Plus GeneChip
48 Purpose5-fluorouracil
49 ResultsPharmacogenetic genotyping
50 TYMS genetic variants distribution
51 analysis
52 approach
53 association
54 backbone
55 cancer patients
56 candidate genetic variants
57 cases
58 chemotherapeutic combination regimens
59 chemotherapy-induced toxicity
60 colorectal cancer patients
61 combination regimens
62 control
63 control patients
64 data
65 dehydrogenase
66 determinants
67 detrimental effects
68 differences
69 dihydropyrimidine dehydrogenase
70 distribution
71 drug metabolism
72 effect
73 enzyme
74 excretion
75 gene polymorphisms
76 genes
77 genetic determinants
78 genetic polymorphisms
79 genetic variants
80 genetic variants distribution
81 genotyping
82 genotyping microarray Affymetrix Drug-Metabolizing Enzymes
83 homogenous treatment
84 innovative genotyping microarray Affymetrix Drug-Metabolizing Enzymes
85 metabolism
86 microarray Affymetrix Drug-Metabolizing Enzymes
87 microarrays
88 minority
89 minority of toxicities
90 new candidate genetic variants
91 new genetic determinants
92 occurrence
93 patients
94 pharmacodynamics
95 pharmacokinetics
96 polymorphism
97 regimens
98 report
99 rs9787901
100 samples
101 severe toxicity
102 significant differences
103 strong association
104 study
105 synthase gene polymorphisms
106 therapy
107 toxicity
108 transport
109 transporters
110 treatment
111 use
112 valid approach
113 variability
114 variant distribution
115 variants
116 schema:name DMET™ (Drug-Metabolizing Enzymes and Transporters) microarray analysis of colorectal cancer patients with severe 5-fluorouracil-induced toxicity
117 schema:pagination 483-488
118 schema:productId N70d60609932245e1bcded60554bd2eb9
119 N988e238be31540639a1504b709ae952d
120 Nba22dc35bf1d45b6ab094e5886c57016
121 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032291442
122 https://doi.org/10.1007/s00280-013-2210-1
123 schema:sdDatePublished 2021-12-01T19:30
124 schema:sdLicense https://scigraph.springernature.com/explorer/license/
125 schema:sdPublisher Nd6d3bad718f547658ff957e7deaacc03
126 schema:url https://doi.org/10.1007/s00280-013-2210-1
127 sgo:license sg:explorer/license/
128 sgo:sdDataset articles
129 rdf:type schema:ScholarlyArticle
130 N10cfb2d194c64d9dbb40dc3a0c8507f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Male
132 rdf:type schema:DefinedTerm
133 N1458180e824645f0850e5ad8ace8c521 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Mutagenesis, Insertional
135 rdf:type schema:DefinedTerm
136 N180545b060814c6c9adb03bd083932e5 rdf:first sg:person.01174611161.20
137 rdf:rest N9e9c7457bceb4f4389d3036609b8be88
138 N304c3de0c74d4b0c9243fcee067ea5ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Polymorphism, Single Nucleotide
140 rdf:type schema:DefinedTerm
141 N37469ddd80e04c24913f4e37b722a9f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Antimetabolites, Antineoplastic
143 rdf:type schema:DefinedTerm
144 N46851e7a373f45d39e6bde26f7813526 rdf:first sg:person.0600652745.06
145 rdf:rest Nf3919fdf132c402388dceb7cc577d230
146 N553f93ccf3884d648ebeedd461df1950 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Gene Dosage
148 rdf:type schema:DefinedTerm
149 N6095769b702e4e9795fc26edc215e968 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Fluorouracil
151 rdf:type schema:DefinedTerm
152 N62823736846b434b84f576126bf9f821 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Thymidylate Synthase
154 rdf:type schema:DefinedTerm
155 N6757db1e348b457f81d3e5ca690744c9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Pharmaceutical Preparations
157 rdf:type schema:DefinedTerm
158 N6db7f6cb8711468d8bfdc4294b2586aa schema:volumeNumber 72
159 rdf:type schema:PublicationVolume
160 N70d60609932245e1bcded60554bd2eb9 schema:name dimensions_id
161 schema:value pub.1032291442
162 rdf:type schema:PropertyValue
163 N7222c445c9c64be0a6e593c26b1402c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Microarray Analysis
165 rdf:type schema:DefinedTerm
166 N72238aca9cf144d3b770f089bcc64d18 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Dihydrouracil Dehydrogenase (NADP)
168 rdf:type schema:DefinedTerm
169 N74ea7aecae9747ac9fc40b8853f71987 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Colorectal Neoplasms
171 rdf:type schema:DefinedTerm
172 N9367311168524a66bab70f990649fe09 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name 5' Untranslated Regions
174 rdf:type schema:DefinedTerm
175 N988e238be31540639a1504b709ae952d schema:name doi
176 schema:value 10.1007/s00280-013-2210-1
177 rdf:type schema:PropertyValue
178 N9bb3ff9dc760438398e4ac8bdd277db0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Sulfotransferases
180 rdf:type schema:DefinedTerm
181 N9e9c7457bceb4f4389d3036609b8be88 rdf:first sg:person.0730464170.02
182 rdf:rest N46851e7a373f45d39e6bde26f7813526
183 Na2f0888ab7124941ac9b05a30a8f21ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Membrane Transport Proteins
185 rdf:type schema:DefinedTerm
186 Nab670325b66544eca4755b10debd3daa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Humans
188 rdf:type schema:DefinedTerm
189 Nae26aa2d05bf4cb892ce0504d520f53b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Gene Deletion
191 rdf:type schema:DefinedTerm
192 Nb1ffdcf506994338805807a6987dc78a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Genotype
194 rdf:type schema:DefinedTerm
195 Nb5f43d1d989a484f90b7d2f9547172fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Female
197 rdf:type schema:DefinedTerm
198 Nba22dc35bf1d45b6ab094e5886c57016 schema:name pubmed_id
199 schema:value 23760813
200 rdf:type schema:PropertyValue
201 Nc8bc6f76b80d414eac3c4fc5fd73442e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
202 schema:name Glutathione Transferase
203 rdf:type schema:DefinedTerm
204 Nd36651f03ae2418c9b6decbbf5986380 schema:issueNumber 2
205 rdf:type schema:PublicationIssue
206 Nd6d3bad718f547658ff957e7deaacc03 schema:name Springer Nature - SN SciGraph project
207 rdf:type schema:Organization
208 Nf3919fdf132c402388dceb7cc577d230 rdf:first sg:person.01242265602.64
209 rdf:rest rdf:nil
210 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
211 schema:name Medical and Health Sciences
212 rdf:type schema:DefinedTerm
213 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
214 schema:name Oncology and Carcinogenesis
215 rdf:type schema:DefinedTerm
216 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
217 schema:name Pharmacology and Pharmaceutical Sciences
218 rdf:type schema:DefinedTerm
219 sg:journal.1088364 schema:issn 0344-5704
220 1432-0843
221 schema:name Cancer Chemotherapy and Pharmacology
222 schema:publisher Springer Nature
223 rdf:type schema:Periodical
224 sg:person.01174611161.20 schema:affiliation grid-institutes:grid.419546.b
225 schema:familyName Rumiato
226 schema:givenName Enrica
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174611161.20
228 rdf:type schema:Person
229 sg:person.01242265602.64 schema:affiliation grid-institutes:grid.419546.b
230 schema:familyName Saggioro
231 schema:givenName Daniela
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242265602.64
233 rdf:type schema:Person
234 sg:person.0600652745.06 schema:affiliation grid-institutes:grid.5608.b
235 schema:familyName Amadori
236 schema:givenName Alberto
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600652745.06
238 rdf:type schema:Person
239 sg:person.0730464170.02 schema:affiliation grid-institutes:grid.419546.b
240 schema:familyName Boldrin
241 schema:givenName Elisa
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730464170.02
243 rdf:type schema:Person
244 sg:pub.10.1007/s10038-002-8650-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053724153
245 https://doi.org/10.1007/s10038-002-8650-9
246 rdf:type schema:CreativeWork
247 sg:pub.10.1038/sj.bjc.6605052 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007371493
248 https://doi.org/10.1038/sj.bjc.6605052
249 rdf:type schema:CreativeWork
250 sg:pub.10.1038/sj.tpj.6500012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032976098
251 https://doi.org/10.1038/sj.tpj.6500012
252 rdf:type schema:CreativeWork
253 sg:pub.10.1038/tpj.2009.45 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043532859
254 https://doi.org/10.1038/tpj.2009.45
255 rdf:type schema:CreativeWork
256 sg:pub.10.1186/1471-2105-13-258 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041082187
257 https://doi.org/10.1186/1471-2105-13-258
258 rdf:type schema:CreativeWork
259 grid-institutes:grid.419546.b schema:alternateName Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Via Gattamelata 64, 35128, Padova, Italy
260 schema:name Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Via Gattamelata 64, 35128, Padova, Italy
261 rdf:type schema:Organization
262 grid-institutes:grid.5608.b schema:alternateName Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy
263 schema:name Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy
264 Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Via Gattamelata 64, 35128, Padova, Italy
265 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...